Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.00
Bid: 244.00
Ask: 250.00
Change: -18.00 (-6.79%)
Spread: 6.00 (2.459%)
Open: 265.00
High: 265.00
Low: 237.00
Prev. Close: 265.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

Fri, 27th Jan 2023 10:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Inspecs Group PLC, up 15% at 108.00 pence, 12-month range 38.50p-400p. The Bath, England-based eyewear company extends rally from Thursday. On Thursday, Inspecs said full-year trading was in line with expectations, despite Covid-19 restrictions in China and Vietnam. The company predicted revenue for 2022 to be USD246.0 million, flat from USD246.5 million in 2021. It said on a constant exchange rate basis, revenue increased by 9.5%. Looking ahead, Inspecs said it has entered 2023 with a good order book, and it hopes to continue to seek operational efficiencies and reduce costs where appropriate.

----------

AIM - LOSERS

----------

Faron Pharmaceuticals Ltd, down 5.9% at 319.80p, 12-month range 155p-395p. The biopharmaceutical company raises EUR12.0 million from a placing of 3.7 million shares at the issue price of EUR3.25. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023. The main reason for the placing is to accelerate and expand the clinical development of the company's main drug candidate, bexmarilimab.

----------

Goldstone Resources Ltd, down 8.3% at 3.53p, 12-month range 3p-10.75p. The Jersey, UK-based gold development company issues GBP2.4 million of convertible loan notes to Blue Gold International Ltd, which are due for redemption on November 30, 2023. The notes may be converted at any time prior to redemption into new ordinary shares of 1p each in the capital of the Goldstone at a conversion price of GBP0.0325 per share. BGL also receives warrants to subscribe for up to 60.0 million shares at a price of GBP0.04 per share, at any time until January 26, 2025.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Mar 2021 09:32

Faron Pharmaceuticals shares boosted by positive data on cancer drug

Faron Pharmaceuticals shares boosted by positive data on cancer drug

Read more
18 Mar 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12 Feb 2021 10:40

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Read more
11 Feb 2021 17:49

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

Read more
26 Jan 2021 11:45

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

Read more
20 Jan 2021 15:12

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
18 Jan 2021 10:41

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

Read more
18 Jan 2021 10:22

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Read more
23 Nov 2020 21:12

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

Read more
24 Sep 2020 14:02

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

Read more
17 Sep 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Aug 2020 11:55

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Read more
15 Jun 2020 13:05

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

Read more
15 Jun 2020 12:44

Faron Pharmaceuticals gets Finnish state loan for manufacturing process

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced plans to initiate a new "state-of-the-art" process for the manufacturing of 'interferon' (IFN) beta-1a on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.